SPECIFIC PHARMA A/S — Credit Rating and Financial Key Figures

SPECIFIC PHARMA A/S (CVR number: 33161395) is a company from KØBENHAVN. The company reported a net sales of 211 mDKK in 2023, demonstrating a growth of 18.8 % compared to the previous year. The operating profit percentage was at 13.6 % (EBIT: 28.8 mDKK), while net earnings were 25.6 mDKK. The profitability of the company measured by Return on Assets (ROA) was 28.5 %, which can be considered excellent and Return on Equity (ROE) was 26.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 84.2 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. SPECIFIC PHARMA A/S's liquidity measured by quick ratio was 5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.